This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ai, M. Articles by Reaven, G. M. Search for Related Content PubMed PubMed Citation Articles by Ai, M. Articles by Reaven, G. M.

Relationship between Hyperinsulinemia and Remnant Lipoprotein Concentrations in Patients with Impaired Glucose Tolerance

Third Department of Internal Medicine, Tokyo Medical and Dental University, Tokyo 113-8519, Japan; Department of Internal Medicine, Tokyo Metropolitan Kiyose Hospital (K.O., M.S., F.N.), Tokyo 204-0023, Japan; and Stanford University School of Medicine (G.M.R.), Stanford, California 94305-5406

Address all correspondence and requests for reprints to: Akira Tanaka, M.D., Third Department of Internal Medicine, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan. address: tanaka.med3{at}med.tmd.ac.jp

This study was performed to explore further the association between insulin resistance and plasma remnant lipoprotein (RLP) concentration. For this purpose we used the sum of the plasma insulin concentrations before and 30, 60, 90, 120, and 180 min after a 75-g oral glucose load (IRI) as a surrogate measure of insulin resistance in 61 subjects with impaired glucose tolerance. IRI was determined on 2 occasions, before and 16 weeks after initiation of a diet and exercise program. At baseline, IRI correlated with the sum of the plasma glucose concentrations in response to the 75-g oral glucose load (r = 0.26; P < 0.04) as well as plasma concentrations of triglyceride (r = 0.21; P = 0.09), RLP-cholesterol (r = 0.41; P < 0.001), and RLP-triglyceride (r = 0.46; P < 0.001). In contrast, neither total (r = 0.07) nor high density lipoprotein (HDL) cholesterol (r = 0.04) concentrations correlated with IRI. IRI was lower in 42 subjects following life-style intervention, associated with significant (P < 0.005) reductions in glucose, and fasting glucose, insulin, triglyceride, RLP-cholesterol, and RLP-triglyceride concentrations. However, none of these variables decreased in the 19 subjects whose IRI did not fall. Finally, the change in IRI following intervention with diet and exercise was significantly associated with differences in glucose (r = 0.63; P < 0.001) and fasting glucose (r = 0.26; P < 0.05), insulin (r = 0.79; P < 0.001), triglyceride (r = 0.29; P < 0.03), RLP-cholesterol (r = 0.71; P < 0.001), and RLP-triglyceride (r = 0.49; P < 0.001) concentrations. These results demonstrate that variations in concentrations of RLPs are highly correlated with changes in IRI, consistent with the possibilities that 1) RLP measurements are useful estimates of insulin resistance; and 2) an increase in RLP concentrations may provide the mechanistic link between insulin resistance and coronary heart disease.

This article has been cited by other articles:

				M. Ai, A. Tanaka, K. Shimokado, R. Ohtani, A. Inazu, J. Kobayashi, H. Mabuchi, T. Nakano, and K. Nakajima A deficiency of cholesteryl ester transfer protein whose serum remnant-like particle-triglyceride significantly increased, but serum remnant-like particle-cholesterol did not after an oral fat load Ann Clin Biochem, November 1, 2009; 46(6): 457 - 463. [Abstract] [Full Text] [PDF]

				T. McLaughlin, S. Carter, C. Lamendola, F. Abbasi, G. Yee, P. Schaaf, M. Basina, and G. Reaven Effects of moderate variations in macronutrient composition on weight loss and reduction in cardiovascular disease risk in obese, insulin-resistant adults. Am. J. Clinical Nutrition, October 1, 2006; 84(4): 813 - 821. [Abstract] [Full Text] [PDF]

				M. Ai, A. Tanaka, K. Ogita, and K. Shimokado Favorable Effects of Early Insulin Secretion by Nateglinide on Postprandial Hyperlipidemia in Patients With Type 2 Diabetes Diabetes Care, May 1, 2006; 29(5): 1180 - 1180. [Full Text] [PDF]

				J. W. Chu, F. Abbasi, K. R. Kulkarni, C. Lamendola, T. L. McLaughlin, J. N. Scalisi, and G. M. Reaven Multiple Lipoprotein Abnormalities Associated with Insulin Resistance in Healthy Volunteers Are Identified by the Vertical Auto Profile-II Methodology Clin. Chem., June 1, 2003; 49(6): 1014 - 1017. [Full Text] [PDF]

				M. Fukushima, A. Taniguchi, Y. Nakai, M. Sakai, K. Doi, K. Nin, T. Oguma, S. Nagasaka, K. Tokuyama, and Y. Seino Remnant-Like Particle Cholesterol and Insulin Resistance in Nonobese Nonhypertensive Japanese Glucose-Tolerant Relatives of Type 2 Diabetic Patients Diabetes Care, September 1, 2001; 24(9): 1691 - 1694. [Full Text] [PDF]